The Safety-Net Antibiotic Prescription (SNAP) Strategy: A Comprehensive Examination for Optimized Pediatric Antimicrobial Stewardship

Many thanks to our sponsor Esdebe who helped us prepare this research report.

Abstract

The escalating crisis of antimicrobial resistance (AMR) demands innovative and judicious approaches to antibiotic prescribing, particularly within vulnerable pediatric populations. The Safety-Net Antibiotic Prescription (SNAP) represents a forward-thinking strategy designed to optimize antibiotic use in mild pediatric infections, primarily pneumonia. This report provides an exhaustive analysis of the SNAP strategy, tracing its conceptual genesis and theoretical foundations amidst the global AMR challenge. It delves into the extant evidence regarding its efficacy and safety, not only in its primary application to pediatric pneumonia but also in other relevant clinical conditions. Furthermore, this examination meticulously details the critical communication frameworks necessary for clinicians, outlines multifaceted strategies to bolster parental engagement and adherence, and situates SNAP within the broader architecture of antimicrobial stewardship programs. Through an exploration of case studies illustrating its adoption across diverse healthcare systems and populations, the report illuminates both the profound potential and the inherent challenges associated with its widespread implementation. It concludes by delineating crucial future research directions aimed at refining and expanding the application of SNAP to combat AMR effectively.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

1. Introduction: Navigating the Crisis of Antimicrobial Resistance in Pediatric Care

Antimicrobial resistance (AMR) stands as one of the most pressing and complex global health threats of the 21st century, with profound implications for human health, economic stability, and societal well-being. The efficacy of antimicrobial agents, which have been foundational to modern medicine, is progressively eroding, leading to prolonged illnesses, increased mortality rates, and exorbitant healthcare costs. The World Health Organization (WHO) and other international bodies have consistently highlighted the urgent need for concerted global action to mitigate this crisis.

Pediatric populations are uniquely vulnerable within the AMR landscape. Children frequently experience a high burden of infectious diseases, leading to considerable antibiotic exposure. Many common childhood infections, such as respiratory tract infections and otitis media, are often viral in etiology, yet antibiotics are frequently prescribed due to diagnostic uncertainty, parental pressure, or clinician habit. This pervasive overuse and misuse of antibiotics in children contribute significantly to the development and spread of resistant pathogens, jeopardizing the effectiveness of treatments for serious bacterial infections later in life. For instance, community-acquired pneumonia (CAP) in children, a common diagnosis, presents a particular challenge as differentiating between viral and bacterial etiologies can be difficult in routine clinical practice, often leading to presumptive antibiotic therapy.

In response to this critical imperative to conserve antibiotic effectiveness, innovative strategies are urgently required to optimize antibiotic use, particularly in settings where diagnostic ambiguity is high and the potential for viral illness is substantial. The Safety-Net Antibiotic Prescription (SNAP) strategy has emerged as a pragmatic and patient-centered intervention designed to address this delicate balance. SNAP involves the provision of an antibiotic prescription to parents for mild pediatric conditions, but with explicit instructions to delay its dispensation and administration unless the child’s symptoms demonstrably worsen or fail to improve within a specified timeframe. This nuanced approach aims to reduce unnecessary antibiotic exposure while simultaneously ensuring that children who genuinely require antibiotics receive timely treatment, thereby upholding patient safety and parental confidence. This comprehensive report aims to dissect the multifaceted aspects of SNAP, providing a detailed understanding of its role in fostering responsible antimicrobial stewardship.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

2. Historical Development and Theoretical Basis of SNAP

The concept of the Safety-Net Antibiotic Prescription is not an isolated innovation but rather a natural evolution of clinical practice in the face of mounting evidence regarding antibiotic resistance and a deeper understanding of the natural history of many common pediatric infections. To fully appreciate SNAP, it is essential to contextualize its development within the broader history of antibiotic discovery, the subsequent rise of AMR, and the concurrent evolution of antimicrobial stewardship principles.

2.1 The Dawn of the Antibiotic Era and the Rise of Resistance

The discovery of penicillin by Alexander Fleming in 1928, and its subsequent mass production in the 1940s, heralded a revolutionary era in medicine. Antibiotics transformed the landscape of infectious diseases, dramatically reducing morbidity and mortality from previously fatal conditions. However, the very success of antibiotics inadvertently laid the groundwork for the emergence of resistance. Early warnings from Fleming himself, who cautioned against the misuse of penicillin, were largely overlooked amidst the enthusiasm for these ‘miracle drugs.’ Over the decades, antibiotics became widely and often indiscriminately used in human medicine, agriculture, and animal husbandry, creating immense selective pressure that favored the survival and proliferation of resistant microbial strains.

By the late 20th and early 21st centuries, the scale of AMR had become undeniable. Pathogens resistant to multiple antibiotic classes, such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE), became prevalent, posing severe challenges to healthcare systems worldwide. This escalating crisis necessitated a fundamental shift in how antibiotics were perceived and utilized – from a readily available panacea to a precious and finite resource requiring careful management.

2.2 Evolution of Antimicrobial Stewardship and the Concept of ‘Watchful Waiting’

The recognition of AMR’s gravity led to the formalization of antimicrobial stewardship programs (ASPs). These programs are designed to optimize antimicrobial prescribing and use, improve patient outcomes, reduce Clostridioides difficile infection, and combat AMR. Key principles of stewardship include prescribing the right drug, at the right dose, for the right duration, when truly needed. A crucial component of this philosophy is the judicious deferral of antibiotics when clinical evidence suggests a high probability of viral etiology or when the benefits of immediate treatment do not outweigh the risks of antibiotic exposure.

The concept of ‘watchful waiting’ or ‘delayed prescribing’ is a precursor and theoretical cornerstone of SNAP. It originated in the management of self-limiting conditions like acute otitis media (AOM) and acute sinusitis, particularly in children. Studies demonstrated that many cases of AOM, for instance, resolve spontaneously without antibiotic intervention, and that delaying antibiotics for a short period did not lead to worse outcomes for most children while significantly reducing antibiotic consumption. This evidence provided a robust foundation for extending similar principles to other conditions where viral etiology is common, such as mild pediatric community-acquired pneumonia (CAP).

2.3 The Specific Challenge of Pediatric Pneumonia and SNAP’s Rationale

Pediatric CAP is a leading cause of childhood morbidity and mortality globally. While bacterial pneumonia requires prompt antibiotic treatment, a substantial proportion of CAP in children, particularly those with milder presentations, is caused by viruses. Differentiating between bacterial and viral pneumonia based solely on clinical signs and symptoms can be challenging, especially in primary care or emergency department settings where rapid diagnostic tests may not be readily available or are underutilized. This diagnostic uncertainty often leads to empiric antibiotic prescribing ‘just in case’ it is bacterial, contributing to unnecessary antibiotic use.

SNAP directly addresses this dilemma. Its theoretical basis rests on several key understandings:

• Natural History of Illness: Many mild pediatric respiratory infections, including some cases initially presenting as pneumonia, are self-limiting and resolve spontaneously.
• Risk-Benefit Analysis: For carefully selected children with mild pneumonia, the immediate risk of withholding antibiotics for a short observation period is often low, especially when balanced against the collective and individual risks of unnecessary antibiotic exposure (e.g., side effects, disruption of microbiome, contribution to AMR).
• Parental Empowerment and Shared Decision-Making: SNAP empowers parents by involving them in the decision-making process and providing them with an actionable plan, fostering a sense of control and collaboration with their clinician. It shifts the paradigm from immediate, unconditional prescribing to a more nuanced, conditional approach.
• Behavioral Economics: SNAP leverages behavioral principles by providing a ‘safety net’ (the prescription) while subtly nudging towards delayed use. It acknowledges the psychological comfort that an antibiotic prescription provides to parents while guiding them towards a more conservative approach if clinically appropriate.

By prescribing antibiotics but delaying their immediate dispensation, SNAP offers a compromise: it satisfies the parental desire for a therapeutic option while promoting judicious use. This approach is intended to reduce the overall volume of antibiotics consumed, thereby supporting broader antimicrobial stewardship goals without compromising patient safety for appropriate candidates.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

3. Review of Existing Evidence for Efficacy and Safety

The implementation of SNAP relies on a robust evidence base demonstrating its efficacy in reducing antibiotic use without compromising patient safety. While the concept of delayed prescribing has been explored for other conditions, its specific application as a ‘safety-net’ strategy in pediatric pneumonia is a more recent focus of rigorous investigation.

3.1 Efficacy in Pediatric Pneumonia

The primary target condition for SNAP’s current evaluation is mild pediatric community-acquired pneumonia (CAP). The rationale is particularly strong here due to the high incidence of viral etiologies and the challenges in rapid differentiation. Studies investigating SNAP in this context typically aim to compare immediate antibiotic prescribing with the SNAP approach, measuring key outcomes such as antibiotic consumption, clinical failure rates, hospitalizations, complications, and patient/parent satisfaction.

A significant study funded by the Patient-Centered Outcomes Research Institute (PCORI) is actively underway, directly addressing this gap in evidence. This large-scale clinical trial aims to compare immediate antibiotic prescribing with the SNAP approach in children diagnosed with mild pneumonia. The primary objective of this research is to rigorously determine whether SNAP leads to a quantifiable decrease in antibiotic use while maintaining comparable clinical improvement and safety outcomes when juxtaposed with the conventional immediate prescribing paradigm (Florin ME, et al., 2024). The importance of such a trial cannot be overstated, as it seeks to provide definitive evidence on the practicality and effectiveness of SNAP for a widespread pediatric condition, which is crucial for informing clinical guidelines and policy.

Preliminary findings and smaller observational studies, while not as definitive as large randomized controlled trials, generally support the feasibility and potential benefits of SNAP in reducing antibiotic usage for respiratory tract infections in children. These studies often highlight a significant reduction in dispensed prescriptions when a delayed strategy is employed, without a corresponding increase in adverse outcomes or re-consultations, provided that appropriate patient selection and clear communication are in place.

3.2 Efficacy in Other Conditions

The principles underlying SNAP – judicious antibiotic use, delayed prescribing, and patient/parent empowerment – are not unique to pediatric pneumonia. They are broadly applicable to other common pediatric infections where viral etiologies are prevalent or where a significant proportion of bacterial cases resolve spontaneously.

• Acute Otitis Media (AOM): This is perhaps the most well-studied condition for delayed antibiotic prescribing. Extensive research has shown that in selected children (e.g., those older than 6 months with non-severe AOM), a period of watchful waiting without immediate antibiotics is often safe and effective. The SNAP strategy directly formalizes this watchful waiting into a tangible, proactive plan for parents. A quality improvement study in pediatric emergency departments, for instance, explicitly aimed to increase the percentage of SNAPs offered to patients diagnosed with AOM (PubMed.ncbi.nlm.nih.gov/35226640/). The study found a positive correlation between improved clinician documentation of SNAP eligibility and an increase in the offering of SNAPs, suggesting that clinician awareness and proper application of criteria are key to broader adoption. This indicates that the SNAP framework can be effectively adapted for AOM, leveraging existing evidence for delayed therapy.

• Acute Pharyngitis (Sore Throat): While rapid antigen detection tests (RADT) for Group A Streptococcus (GAS) are widely available, cases where RADT is negative (suggesting viral etiology) but clinician or parental pressure for antibiotics persists could be a target for SNAP. Similarly, in contexts where testing is not immediately available, SNAP could be used while awaiting culture results, with instructions to fill the prescription only if GAS is confirmed or symptoms significantly worsen.

• Acute Sinusitis: The majority of acute sinusitis cases are viral and self-limiting. For mild to moderate cases, particularly in children, a delayed antibiotic strategy (similar to watchful waiting) is often recommended. SNAP provides a structured approach to this recommendation, giving parents a concrete plan if symptoms persist beyond a viral illness timeframe (e.g., 7-10 days) or significantly worsen.

• Bronchiolitis and Non-Specific Upper Respiratory Tract Infections (URTIs): Although antibiotics are generally not indicated for these primarily viral conditions, they are still frequently prescribed. SNAP could serve as an educational tool and a mechanism to gently resist inappropriate prescribing pressure, reinforcing that antibiotics are reserved for specific bacterial indications, which the provided safety-net prescription covers only if those specific bacterial indicators develop.

The applicability of SNAP to these conditions hinges on careful patient selection, clear communication about the natural history of the illness, and specific ‘red flag’ symptoms that would necessitate antibiotic initiation. The success of its application across various conditions underscores the versatility of the SNAP framework as a tool within antimicrobial stewardship.

3.3 Safety Considerations

The paramount concern with any strategy involving delayed treatment, especially in pediatric populations, is patient safety. Critics and cautious clinicians often raise concerns about the potential for delayed diagnosis of bacterial infection, progression to severe illness, or complications if antibiotics are withheld. However, the design of SNAP explicitly addresses these concerns through rigorous patient selection and robust safety protocols.

• Patient Selection: SNAP is strictly intended for children with mild presentations of infections where a significant proportion are viral or self-limiting, and where the risk of rapid deterioration is low. Children with severe symptoms, underlying comorbidities (e.g., immunodeficiency, complex congenital heart disease), or signs suggestive of sepsis are never candidates for SNAP and require immediate and often broad-spectrum antibiotic therapy.

• Clear ‘Red Flag’ Instructions: A cornerstone of SNAP’s safety is the provision of explicit, unambiguous instructions to parents regarding what symptoms warrant filling the prescription and/or seeking immediate medical attention. These ‘red flags’ typically include persistent high fever, worsening respiratory distress, signs of dehydration, new onset of severe pain, or any symptom that significantly deviates from the expected mild course of illness.

• Risk of Complications: For pediatric pneumonia, potential complications of delayed treatment could include empyema, lung abscess, or bacteremia. However, for mild, well-selected cases, the incidence of these severe complications without immediate antibiotics, when carefully monitored, has been shown to be low. The ‘safety net’ aspect of the prescription is precisely designed to mitigate this risk by allowing parents to initiate treatment promptly should the child’s condition genuinely worsen.

• Parental Anxiety vs. Actual Risk: A significant aspect of safety relates to managing parental anxiety. While a delayed approach might initially cause apprehension, studies on watchful waiting have generally shown high parental satisfaction when communication is clear and supportive. Parents often appreciate the opportunity to avoid unnecessary medication, provided they feel confident in the safety net and the clinician’s guidance.

• Addressing Inappropriate Prescribing: A study examining inappropriate antibiotic prescribing in safety-net populations found that such prescribing was common (PubMed.ncbi.nlm.nih.gov/38671203/). This highlights a systemic issue where antibiotics are often used without clear indication, potentially due to factors like diagnostic uncertainty, lack of time, or patient pressure. Strategies like SNAP are precisely designed to address this by providing a structured, evidence-based alternative to immediate, often inappropriate, prescribing, thereby improving overall antibiotic appropriateness and safety by reducing unnecessary exposure.

In essence, the safety of SNAP is not about withholding necessary treatment, but rather about ensuring appropriate treatment at the appropriate time, guided by careful clinical assessment and robust patient monitoring guidelines.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

4. Communication Frameworks for Clinicians: Building Trust and Understanding

Effective communication is not merely an adjunct but an indispensable cornerstone for the successful implementation and acceptance of the Safety-Net Antibiotic Prescription strategy. For SNAP to achieve its goals, clinicians must master the art of conveying complex medical information, managing expectations, alleviating anxieties, and fostering a collaborative partnership with parents. A robust communication framework is critical to overcome potential resistance from both clinicians and parents and ensure adherence to the strategy.

4.1 Principles of Shared Decision-Making

SNAP inherently aligns with the principles of shared decision-making, where clinicians and patients (or in pediatrics, parents/guardians) collaborate to make healthcare choices based on the best available evidence, the clinician’s expertise, and the patient’s values and preferences. For SNAP, this involves:

• Presenting Options: Clinicians must clearly articulate the two primary options: immediate antibiotic treatment or the SNAP approach (delayed treatment with a safety-net prescription).
• Explaining Evidence: The rationale for SNAP, grounded in the prevalence of viral etiologies, the natural history of the mild illness, and the risks of unnecessary antibiotic use, must be explained in an understandable, non-jargonistic manner.
• Eliciting Preferences: Parents’ concerns, prior experiences with antibiotics, and comfort level with delayed treatment must be actively sought and acknowledged.
• Collaborative Plan: Together, the clinician and parents arrive at a mutually agreeable plan that ensures the child’s safety and well-being.

4.2 Key Elements of Communication During a SNAP Consultation

During a SNAP consultation, clinicians need to systematically address several critical points to ensure clarity and build confidence:

1. Diagnosis and Etiology: Clearly explain the diagnosis (e.g., ‘mild pneumonia likely viral’) and the likely cause. Emphasize that many mild cases resolve without antibiotics. ‘We believe your child’s pneumonia is likely caused by a virus, similar to a common cold, which antibiotics won’t help.’
2. Rationale for Delayed Antibiotic Use: Articulate the benefits of delaying antibiotics, focusing on both individual child benefits (avoiding side effects, protecting gut microbiome) and population-level benefits (combating AMR). ‘Giving antibiotics when they’re not needed can cause side effects like diarrhea, rash, or upset stomachs. It also contributes to antibiotic resistance, making these medicines less effective when they are truly needed for serious infections.’
3. The ‘Safety Net’ Concept: Explain precisely what the safety-net prescription entails. ‘I am giving you an antibiotic prescription today. Think of it as a ‘safety net.’ You will only need to fill this prescription and start the medication if your child’s symptoms worsen significantly or don’t improve after [specified timeframe, e.g., 2-3 days].’
4. Symptom Monitoring and Expected Course: Provide explicit instructions on what symptoms to monitor, what improvements to expect, and the typical duration of the illness. ‘Keep a close eye on your child’s fever and breathing. We expect the fever to gradually decrease, and their cough might linger for a week or two. If they are eating, drinking, and playing reasonably, that’s a good sign.’
5. ‘Red Flag’ Symptoms and When to Act: This is perhaps the most crucial safety component. Clinicians must clearly list specific ‘red flag’ symptoms that necessitate immediate action—either filling the prescription or seeking urgent medical review. ‘You should fill the prescription and start the antibiotics, or call us/return to the clinic, if your child develops a persistent high fever (above 102°F or 39°C) for more than 48 hours, has difficulty breathing, appears lethargic, or isn’t eating or drinking.’ This needs to be written down for parents to refer to.
6. Follow-up Plan: Outline clear follow-up instructions, whether it’s a scheduled phone call, an option for an in-person visit if concerns arise, or guidance on when to simply continue home care. ‘Please feel free to call us at any point if you have concerns. We can schedule a follow-up call in 48 hours to check in.’

4.3 Addressing Clinician Concerns and Training

Clinicians themselves may harbor concerns about implementing SNAP, including diagnostic uncertainty, fear of medico-legal repercussions if a child’s condition worsens, pressure from parents for immediate antibiotics, or simply a lack of familiarity with the strategy. Effective communication frameworks must also consider these clinician-side barriers:

• Training and Education: Provide comprehensive training on patient selection criteria for SNAP, the evidence base, and effective communication techniques. This training should include role-playing scenarios to practice difficult conversations with parents.
• Clinical Decision Support Tools: Implement electronic health record (EHR) prompts or clinical pathways that guide clinicians in identifying appropriate SNAP candidates and provide standardized communication templates or patient handouts.
• Peer Support and Mentorship: Create opportunities for clinicians experienced with SNAP to mentor those who are new to the strategy, fostering a supportive environment for practice change.
• Addressing Medico-Legal Anxieties: Emphasize that SNAP, when implemented according to evidence-based guidelines with robust communication and safety nets, is a medically sound and defensible practice that prioritizes appropriate care and reduces unnecessary antibiotic exposure.

Establishing trust is paramount. Parents need to feel that their clinician is genuinely invested in their child’s well-being and is not simply ‘withholding’ treatment. By being transparent, empathetic, and providing a clear, actionable plan, clinicians can build this trust and significantly enhance the likelihood of SNAP’s success.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

5. Strategies to Enhance Parental Engagement and Adherence

The success of the Safety-Net Antibiotic Prescription strategy hinges critically on parental engagement and adherence. Even the most meticulously designed clinical guideline will fail if parents do not understand, accept, or follow the instructions for delayed antibiotic use. Therefore, implementing effective strategies to empower parents and ensure their active participation is fundamental.

5.1 Understanding Parental Perspectives: Barriers to Adherence

Before implementing engagement strategies, it is crucial to understand the common reasons why parents might be hesitant or non-adherent to SNAP:

• Anxiety and Fear: Parents are naturally anxious when their child is unwell, and there’s an inherent instinct to seek immediate relief. The idea of delaying treatment might heighten this anxiety, fueled by concerns about worsening illness or complications.
• Lack of Understanding: Misconceptions about antibiotics (e.g., they cure all infections, they speed recovery from viral illness) are widespread. Without clear explanations, parents might not grasp the rationale for SNAP.
• Prior Experiences: If a child has previously responded well to immediate antibiotics, parents may expect the same approach, believing it to be the ‘best’ or ‘only’ way to treat.
• Trust in Clinician: A lack of trust in the clinician or the healthcare system can lead parents to disregard advice, potentially seeking a second opinion or filling the prescription regardless of instructions.
• Socioeconomic and Cultural Factors: Health literacy levels vary significantly. Cultural beliefs about illness and medication, as well as practical barriers like access to pharmacies, transportation for follow-up, or the cost of delayed prescriptions, can impact adherence. Parents in safety-net populations, for instance, may face additional challenges that influence their ability to adhere to complex medical instructions.
• Communication Gaps: Inadequate or unclear communication from the clinician can leave parents confused and less likely to follow the plan.

5.2 Empowering Parents Through Education and Resources

Effective education is the cornerstone of parental engagement. This goes beyond a brief verbal explanation during the consultation:

• Clear, Concise Educational Materials: Provide parents with written handouts, leaflets, or digital resources (e.g., links to websites or videos) that reinforce the verbal instructions. These materials should be culturally sensitive, available in multiple languages, and written in plain, accessible language. They should explain:
  • What SNAP is and why it’s being recommended.
  • The difference between viral and bacterial infections.
  • Expected symptom course and duration.
  • Specific ‘red flag’ symptoms requiring action.
  • Instructions on when and how to fill and administer the antibiotic.
  • Contact information for questions or concerns.
• Decision Aids: Tools that help parents weigh the pros and cons of immediate vs. delayed antibiotics can facilitate shared decision-making and enhance understanding.
• Visual Aids: Infographics or simple diagrams illustrating the expected course of illness or the ‘safety net’ concept can be very effective, especially for parents with lower health literacy.

5.3 Fostering Trust and Shared Understanding

Building a strong, trusting relationship between clinicians and parents is paramount:

• Empathetic Listening: Clinicians must actively listen to parents’ concerns, validate their anxieties, and address them directly. Acknowledging their worry is key to building rapport.
• Reassurance and Support: Reassure parents that the child’s safety is the top priority and that the SNAP strategy has been carefully considered. Emphasize that they are not alone in monitoring their child and that support is available.
• Collaborative Language: Use inclusive language, such as ‘we will monitor’ or ‘our plan is,’ to foster a sense of partnership.
• Respecting Parental Knowledge: Acknowledge that parents know their children best. Their observations are invaluable in monitoring symptom progression.
• Cultural Competence: Understand and respect diverse cultural perspectives on illness, healing, and medication. Tailor communication to be culturally appropriate.

5.4 Practical Strategies to Support Adherence

Beyond education and trust-building, practical mechanisms can bolster adherence:

• Follow-up Mechanisms: Implement proactive follow-up, such as a scheduled phone call from the clinic nurse or clinician within 24-48 hours. This check-in provides an opportunity to answer questions, assess symptom progression, and reinforce instructions. Digital platforms or patient portals can also facilitate communication and symptom tracking.
• Clear Contact Information: Ensure parents have easy access to contact the clinic or an on-call clinician if they have questions or concerns outside of regular hours.
• Pharmacy Collaboration: Engage local pharmacies to understand the SNAP process. Pharmacists can serve as an additional point of contact for parents with questions about the delayed prescription.
• Addressing Cost Barriers: Be mindful of potential financial barriers to filling a prescription later or attending follow-up appointments, particularly in safety-net populations. Exploring options like telemedicine for follow-up or discussing generic antibiotic options can be helpful.
• Feedback Loops: Establish mechanisms for clinicians to receive feedback on patient outcomes following SNAP, reinforcing confidence in the strategy and providing opportunities for refinement.

Ultimately, enhancing parental engagement and adherence to SNAP requires a multi-pronged approach that combines robust education, empathetic communication, trust-building, and practical support mechanisms. By investing in these strategies, healthcare systems can empower parents to become active partners in responsible antibiotic use, thereby maximizing the potential of SNAP to combat AMR.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

6. Role within Broader Antimicrobial Stewardship Programs

The Safety-Net Antibiotic Prescription (SNAP) strategy is not merely an isolated intervention; it is an integral and highly valuable component within the overarching framework of antimicrobial stewardship programs (ASPs). Its principles and objectives align perfectly with the core tenets of stewardship, making it a powerful tool for optimizing antibiotic use in outpatient settings, particularly within pediatric care.

6.1 Core Components of Antimicrobial Stewardship Programs

Antimicrobial Stewardship Programs are multifaceted initiatives designed to improve the appropriate use of antimicrobial agents. While often associated with inpatient hospital settings, their importance in outpatient and community settings is increasingly recognized, given that the majority of antibiotics are prescribed outside of hospitals. Key pillars of effective ASPs, as outlined by organizations like the Centers for Disease Control and Prevention (CDC) and the WHO, typically include:

• Leadership Commitment: Dedication from leadership to implement and sustain stewardship activities.
• Accountability: Designating a leader or team responsible for program outcomes.
• Drug Expertise: Access to pharmacists or infectious disease specialists.
• Action: Implementing interventions to improve antibiotic use.
• Tracking and Reporting: Monitoring antibiotic prescribing, resistance patterns, and outcomes.
• Education: Providing ongoing education for clinicians, patients, and the public.

SNAP directly contributes to several of these pillars, particularly ‘Action,’ ‘Tracking and Reporting,’ and ‘Education.’

6.2 SNAP as a Targeted Intervention within Outpatient ASPs

SNAP serves as a concrete, actionable intervention within outpatient ASPs, specifically targeting conditions where diagnostic uncertainty is high and viral etiologies are common, such as mild pediatric pneumonia, AOM, and sinusitis. Its role can be understood through several lenses:

• Reduction of Unnecessary Prescriptions: The most direct contribution of SNAP is its ability to reduce the number of dispensed antibiotic prescriptions. By delaying the decision to fill the prescription, a significant proportion of mild infections resolve spontaneously, rendering the antibiotic unnecessary. This directly addresses the ‘Action’ pillar of ASPs by implementing a strategy that actively limits inappropriate antibiotic exposure. This aligns with broader efforts in pediatric antibiotic stewardship for community-acquired pneumonia (Zhang L, et al., 2024), where interventions have shown to improve antibiotic use.

• Promotion of Appropriate Prescribing: SNAP encourages clinicians to pause and critically assess the likelihood of bacterial infection. It shifts the paradigm from reflex prescribing to a more thoughtful, evidence-based approach, ensuring that antibiotics are used only when truly indicated. This enhances the overall appropriateness of antibiotic use, a core goal of stewardship.

• Empowerment of Patients and Families: By engaging parents in the decision-making process and providing them with a clear, actionable plan, SNAP fosters patient-centered care while simultaneously advancing stewardship goals. Educated parents become allies in the fight against AMR, reducing pressure on clinicians for immediate prescriptions. This also aligns with the ‘Education’ pillar, extending it to patient education.

• Data Collection and Feedback: The implementation of SNAP provides valuable data. Tracking the rate of SNAP prescriptions, the rate at which they are actually filled, and subsequent clinical outcomes allows ASPs to monitor the effectiveness of the strategy. This data can then be used for feedback to individual clinicians, departments, and healthcare systems, informing continuous quality improvement initiatives (Neuhauser M, et al., 2018). For example, a national quality improvement collaborative has shown success in improving antibiotic use in pediatric infections (Zhang L, et al., 2024), demonstrating the potential for broader impact.

• Integration with Clinical Decision Support: SNAP can be seamlessly integrated into electronic health record (EHR) systems through clinical decision support tools. These tools can identify appropriate candidates for SNAP, provide guidance on communication, and generate patient-specific instructions, thus standardizing the approach and ensuring consistency across providers.

6.3 Synergies with Other Stewardship Interventions

SNAP operates synergistically with other stewardship interventions:

• Rapid Diagnostics: While SNAP can be effective even without immediate point-of-care testing, its efficacy is enhanced when combined with rapid diagnostic tests (e.g., for influenza, RSV, or strep throat). A negative viral panel might strengthen the rationale for SNAP by further reducing diagnostic uncertainty, confirming that ‘no antibiotic’ is the right initial strategy (Szymczak J, et al., 2024).
• Antibiograms: Local antibiograms, which provide data on antibiotic susceptibility patterns, inform initial empiric choices when antibiotics are initiated, whether immediately or via SNAP.
• Education for Clinicians: Ongoing education on pathogen prevalence, appropriate antibiotic choices, and the natural history of infections reinforces the rationale for SNAP and strengthens clinician confidence in employing delayed prescribing.
• Public Awareness Campaigns: SNAP benefits from and contributes to broader public awareness campaigns about AMR and the importance of appropriate antibiotic use. By experiencing SNAP, parents become more knowledgeable advocates for judicious antibiotic use.

6.4 Impact on Healthcare System Metrics

Successful integration of SNAP within ASPs can yield tangible benefits for healthcare systems:

• Reduced Antibiotic Expenditures: By reducing the number of unnecessarily dispensed antibiotics, healthcare systems can realize cost savings on medication procurement.
• Decreased Adverse Drug Events: Fewer antibiotic exposures lead to fewer antibiotic-associated side effects (e.g., C. difficile infection, allergic reactions), improving patient safety and reducing associated treatment costs.
• Slowing Resistance Development: Over time, a significant reduction in antibiotic consumption, especially for conditions where they are often inappropriately used, contributes to slowing the development and spread of antibiotic-resistant bacteria within the community and healthcare facilities.
• Improved Patient Flow: For minor illnesses, if patients are confident in the SNAP strategy, it may reduce unnecessary follow-up visits, potentially freeing up clinic resources for sicker patients.

In conclusion, SNAP is not a standalone solution but a sophisticated, patient-centered intervention that significantly bolsters the effectiveness of outpatient antimicrobial stewardship programs. By carefully balancing patient safety with the critical imperative to reduce antibiotic overuse, SNAP represents a powerful example of how judicious prescribing practices can contribute to the long-term preservation of antibiotic efficacy.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

7. Case Studies of Adoption in Different Healthcare Systems and Populations

The implementation of the Safety-Net Antibiotic Prescription (SNAP) strategy is not a one-size-fits-all endeavor. Its successful adoption requires careful consideration of the unique characteristics, resource availability, and socio-cultural contexts of different healthcare systems and populations. Examining case studies, both described in the original article and conceptualized based on broader principles, offers valuable insights into its adaptability and the challenges encountered.

7.1 Safety-Net Hospitals and Resource-Limited Settings

Safety-net hospitals are healthcare facilities that disproportionately serve patients with limited or no health insurance, low incomes, and often complex health and social needs. These institutions often operate with tighter budgets, fewer staff, and may serve populations with lower health literacy or greater barriers to accessing follow-up care. Implementing an intervention like SNAP in such settings presents a unique set of challenges and opportunities.

• Challenges:

  • Resource Constraints: Limited staffing (e.g., fewer nurses for follow-up calls), lack of advanced IT infrastructure for decision support or patient portals, and constraints on educational material development can hinder SNAP’s implementation.
  • Health Literacy and Language Barriers: Patients in safety-net populations may have diverse educational backgrounds and speak various languages, requiring educational materials and communication strategies to be exceptionally clear, simple, and culturally sensitive.
  • Access to Follow-up: Transportation difficulties, childcare issues, and inflexible work schedules can make it challenging for parents to attend follow-up appointments or even receive phone calls, potentially increasing anxiety about delayed treatment.
  • Trust and Prior Experiences: Patients in these settings may have experienced fragmented care or distrust in the healthcare system, making it harder for clinicians to build the trust necessary for a nuanced strategy like SNAP.

• Adaptations and Opportunities:

  • Streamlined Communication: Focus on ultra-clear, concise, visual, and multi-lingual handouts. Utilize community health workers or navigators to provide additional support and reinforcement of SNAP instructions.
  • Robust Follow-up Protocols: Given potential barriers to in-person follow-up, telephone-based follow-up becomes even more critical. Establishing clear protocols for nurses to conduct these calls and escalate concerns can be highly effective. Text message reminders could also be explored.
  • Community Partnerships: Collaborating with community organizations, schools, or social services can help address underlying social determinants of health that impact adherence, such as transportation or access to medications.
  • Leveraging Existing Programs: Integrating SNAP into existing care pathways for common pediatric illnesses can leverage established resources. A study evaluating the long-term outcomes of an antimicrobial stewardship program in a hospital with low baseline antibiotic use found that such programs can lead to sustained reductions in antibiotic use and expenditures (Zhang L, et al., 2024). This suggests that SNAP, as a component of ASP, could be effective in these settings, provided adequate support and resources are allocated to its specific demands.

7.2 Diverse Populations and Cultural Competence

The effectiveness of SNAP is significantly influenced by the demographic, cultural, and socioeconomic characteristics of the population it serves. Tailoring implementation strategies to these diverse factors is essential for equitable and successful adoption.

• Cultural Beliefs about Illness and Treatment: Different cultures may hold varying beliefs about the causes of illness, the efficacy of medication, and the role of the healthcare provider. For instance, some cultures may have a strong expectation for immediate medication as a sign of competent care, while others may prefer traditional remedies first. Clinicians must be trained in cultural competence to respectfully address these perspectives.

• Health Literacy and Education Levels: As mentioned, health literacy profoundly impacts the understanding of complex medical instructions. Simplifying language, avoiding jargon, and using ‘teach-back’ methods (asking parents to explain the plan in their own words) are crucial.

• Socioeconomic Status: Parents from lower socioeconomic backgrounds may face greater challenges in taking time off work for follow-up appointments, accessing pharmacies, or affording medication co-pays. SNAP communication needs to be sensitive to these potential barriers and explore flexible solutions.

• Language Barriers: Providing information in the preferred language of the parents, either through translated materials or professional interpreters, is non-negotiable for effective communication and adherence.

• Example: Rural vs. Urban Settings: In rural settings, access to immediate medical care might be limited. SNAP could be particularly beneficial here, empowering parents with a pre-emptive solution, but it also necessitates robust remote follow-up options (telemedicine, strong phone support). In urban settings with multiple healthcare options, parents might be more likely to seek a second opinion if they are not fully convinced by the SNAP approach, emphasizing the need for strong initial communication.

7.3 International Adoption and Adaptations

While the specific term ‘SNAP’ might be more prevalent in certain Western healthcare contexts, the underlying concept of delayed antibiotic prescribing is explored globally as a stewardship strategy. Adaptations vary based on national guidelines, healthcare infrastructure, and disease burden.

• High-Income Countries: In countries with robust primary care systems, high health literacy, and universal healthcare coverage, SNAP can be more readily integrated. The focus here might be on refining diagnostic algorithms, leveraging digital health tools for monitoring, and further reducing an already relatively low rate of inappropriate prescribing.

• Low- and Middle-Income Countries (LMICs): In LMICs, where the burden of infectious diseases is higher, access to diagnostics limited, and antibiotic availability sometimes unregulated, the application of SNAP would require significant adaptation. While the principle of avoiding unnecessary antibiotics is paramount, the risks associated with delayed treatment for severe infections might be higher due to weaker health systems, limited access to timely follow-up, and higher prevalence of more severe presentations. In such contexts, SNAP might be more selectively applied to very mild cases with clear viral signs, or focus on educational components to combat informal antibiotic use without prescription (Laytner LA, et al., 2024). The emphasis would also be on robust community-level health education to ensure understanding and prevent misuse.

These case studies underscore that while SNAP offers a powerful framework for antimicrobial stewardship, its successful implementation is deeply intertwined with a nuanced understanding of local contexts. Adaptability, cultural competence, and the willingness to tailor strategies to specific population needs are key determinants of its effectiveness across diverse healthcare landscapes.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

8. Challenges and Barriers to Implementation

Despite its compelling theoretical basis and promising early evidence, the widespread implementation of the Safety-Net Antibiotic Prescription (SNAP) strategy faces several significant challenges and barriers. These obstacles span clinician behaviors, parental perceptions, and systemic healthcare issues, requiring multifaceted solutions.

8.1 Clinician-Related Barriers

Clinicians, as primary prescribers, are central to the success of SNAP, yet they often face hurdles in adopting this approach:

• Diagnostic Uncertainty: Differentiating between viral and bacterial infections in children, especially for conditions like pneumonia, can be clinically challenging without advanced diagnostics. The fear of missing a bacterial infection and potential adverse outcomes (medico-legal concerns) often leads to a preference for immediate, empiric antibiotic prescribing. As one physician noted regarding pediatric viral pneumonia, ‘Physicians IDs barriers to ‘no antibiotic’ strategy’ (Szymczak J, et al., 2024), highlighting these very real clinician anxieties.
• Time Constraints: Outpatient clinics and emergency departments are often fast-paced environments. Explaining the SNAP strategy, providing detailed instructions, and addressing parental concerns takes more time than simply writing an immediate prescription. This time pressure can be a significant disincentive.
• Patient and Parental Expectations: Clinicians often face pressure from parents who expect an antibiotic prescription as a solution for their child’s illness. Resisting this pressure and educating parents requires strong communication skills and confidence in the SNAP approach.
• Lack of Training and Familiarity: Many clinicians have been trained in a paradigm of immediate antibiotic treatment for suspected bacterial infections. A shift to delayed prescribing requires specific education, training, and reinforcement to build confidence and competence.
• Fear of Litigation: The perceived risk of legal consequences if a child’s condition worsens, even if the case was carefully selected for SNAP, can deter clinicians from adopting the strategy.
• Lack of System Support: Inadequate clinical decision support tools within electronic health records, absence of standardized patient education materials, or insufficient administrative support for follow-up calls can impede consistent implementation.

8.2 Parental-Related Barriers

Even with the best clinical communication, parents may encounter obstacles to embracing SNAP:

• Anxiety and Mistrust: Parents are inherently protective of their children. The idea of delaying treatment for a sick child can evoke significant anxiety, especially if they perceive antibiotics as benign or essential for recovery. A lack of trust in the clinician or the healthcare system can exacerbate this.
• Misconceptions about Antibiotics: Widespread misinformation about antibiotics (e.g., they work for viruses, they accelerate healing) can make it difficult for parents to understand the rationale for delayed prescribing.
• Logistical Challenges: For parents in underserved communities, filling a delayed prescription might be difficult if they lack reliable transportation, have limited pharmacy access, or face financial barriers (e.g., co-pays) for the antibiotic itself or for subsequent follow-up visits.
• Difficulty Monitoring Symptoms: Some parents may struggle to accurately monitor and interpret their child’s symptoms, leading to uncertainty about when to initiate the antibiotic or seek further medical attention. Language barriers and low health literacy can amplify this challenge.
• Desire for Immediate Action: In acute illness, parents often want a clear, immediate solution. The conditional nature of SNAP might feel less decisive or reassuring than an immediate treatment plan.

8.3 Systemic and Logistical Barriers

Beyond individual clinicians and parents, the broader healthcare system can pose challenges:

• Lack of Standardized Protocols: Without clear, evidence-based guidelines and protocols for SNAP implementation, there can be significant variability in practice, undermining its effectiveness.
• Inadequate Follow-up Infrastructure: SNAP necessitates robust follow-up mechanisms (e.g., scheduled phone calls, telehealth visits). Healthcare systems may lack the staffing, funding, or technological infrastructure to consistently provide this support.
• Reimbursement Models: Current fee-for-service reimbursement models may not adequately compensate clinicians for the additional time required for detailed communication and follow-up inherent in the SNAP strategy. This can disincentivize its adoption.
• Pharmacy Workflow: Pharmacies need to be informed and prepared for delayed prescriptions, which might differ from their standard workflow. Clear communication channels between clinics and pharmacies are essential.
• Data Collection and Feedback: The ability to track SNAP uptake, prescription fill rates, and patient outcomes is crucial for continuous quality improvement but requires robust data systems that may not be universally available.

Overcoming these multifaceted barriers requires a comprehensive, multi-pronged approach that includes targeted education for clinicians and parents, supportive system changes, policy adjustments, and ongoing evaluation. Addressing these challenges is paramount for realizing the full potential of SNAP as a key antimicrobial stewardship intervention.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

9. Future Directions and Research Needs

The Safety-Net Antibiotic Prescription (SNAP) strategy holds significant promise in the fight against antimicrobial resistance, particularly in pediatric care. However, its continued evolution and widespread adoption are contingent upon addressing existing knowledge gaps and exploring new avenues for implementation and optimization. Future research and development efforts should focus on several critical areas.

9.1 Long-term Outcomes and Epidemiological Impact

While current studies often focus on short-term efficacy (e.g., reduced antibiotic use, immediate clinical outcomes), there is a pressing need for research into the long-term impacts of SNAP:

• Antibiotic Resistance Patterns: Longitudinal studies are required to assess whether widespread adoption of SNAP translates into a measurable reduction in the prevalence of antibiotic-resistant bacteria within communities and healthcare settings. This would involve tracking resistance rates for common pediatric pathogens over time in areas with high SNAP uptake. Predictive modeling, as seen in efforts to predict antibiotic resistance patterns using machine learning (Yarrington ME, et al., 2025), could be instrumental here.
• Patient Health Outcomes: Beyond immediate clinical improvement, research should investigate long-term patient health, including rates of recurrent infections, chronic conditions linked to early antibiotic exposure (e.g., asthma, allergies, inflammatory bowel disease), and overall well-being. This would provide a more holistic view of SNAP’s benefit-risk profile.
• Healthcare Costs: Comprehensive health economic analyses are needed to evaluate the cost-effectiveness of SNAP from various perspectives (patient, payer, health system). This should include direct costs (medication, visits) and indirect costs (lost productivity, long-term health complications).
• Impact on Microbiome: Research into the effect of SNAP on the developing pediatric microbiome, compared to immediate antibiotic treatment, could provide valuable insights into its long-term health implications. Understanding the effects of over- and under-dosing antibiotic treatment on bacterial resistance in the presence of an immune system could further refine SNAP strategies (Mallick UK, et al., 2025).

9.2 Expansion to Diverse Settings and Populations

• Varying Healthcare Systems: Further research is needed to adapt and evaluate SNAP across different healthcare models, including those in low- and middle-income countries, where healthcare infrastructure, pathogen prevalence, and resource availability differ significantly.
• Culturally Diverse Populations: Studies should explore culturally tailored communication strategies and patient education materials to enhance SNAP’s acceptance and adherence in various ethnic and linguistic groups. This includes research on how socioeconomic factors impact adherence.
• Older Pediatric Groups and Adolescents: While often focused on younger children, the applicability and acceptance of SNAP in older pediatric populations and adolescents for conditions like bronchitis or sinusitis warrant investigation.

9.3 Refining Implementation Strategies and Overcoming Barriers

• Implementation Science: Research focused on implementation science can identify the most effective strategies for overcoming clinician and parental barriers. This includes studies on optimal clinician training methods, the role of champions, and the impact of different communication styles.
• Technology Integration: Investigating the role of digital health technologies, such as patient portals for symptom tracking, telemedicine for follow-up, and AI-powered clinical decision support for patient selection, is crucial. For instance, can AI assist in risk stratification to more accurately identify ideal SNAP candidates?
• Public Health Campaigns: Research into the effectiveness of public health campaigns in raising awareness about AMR and delayed prescribing can inform broader strategies to support SNAP.
• Policy and Reimbursement: Studies exploring policy changes and alternative reimbursement models that incentivize clinicians for time spent on patient education and follow-up related to SNAP could facilitate its adoption.

9.4 Comparative Effectiveness Research

• Variations of SNAP: Research could compare different variations of SNAP (e.g., different specified waiting periods, different follow-up protocols, different forms of educational materials) to identify the most effective and feasible approaches.
• SNAP vs. Watchful Waiting: While related, the nuances between a formal SNAP (with a prescription in hand) and pure ‘watchful waiting’ should be explored to understand which approach is more acceptable to parents and effective in reducing antibiotic use without compromising safety.

9.5 Ethical Considerations

• Equity of Access: Research into potential inequities in SNAP implementation, ensuring that all children, regardless of socioeconomic status or geographic location, have access to this judicious approach and the necessary follow-up care.
• Shared Decision-Making Metrics: Developing robust metrics to assess the quality of shared decision-making in SNAP consultations, ensuring that parents feel truly empowered and informed.

By systematically addressing these future directions and research needs, the healthcare community can further solidify the evidence base for SNAP, refine its implementation, and unlock its full potential as a critical strategy in the ongoing global effort to combat antibiotic resistance and safeguard public health for future generations.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

10. Conclusion: A Balanced Approach to Pediatric Antimicrobial Stewardship

The Safety-Net Antibiotic Prescription (SNAP) strategy represents a pivotal advancement in the optimization of antibiotic use within pediatric populations, particularly in the context of mild community-acquired pneumonia and other common childhood infections. Born from the urgent global imperative to combat antimicrobial resistance (AMR), SNAP offers a thoughtfully balanced approach that prioritizes patient safety while simultaneously addressing the critical need to reduce unnecessary antibiotic exposure.

This comprehensive report has underscored the historical trajectory of SNAP, evolving from the fundamental principles of ‘watchful waiting’ and judicious prescribing, a necessity underscored by the escalating crisis of AMR. Its theoretical underpinnings are rooted in a nuanced understanding of infection etiologies, risk-benefit analyses for individual patients, and the profound importance of parental engagement in healthcare decisions.

Existing evidence, including ongoing large-scale trials, demonstrates SNAP’s efficacy in significantly reducing antibiotic consumption without compromising clinical outcomes for carefully selected children. Its adaptability extends beyond pediatric pneumonia, showing promise in conditions like acute otitis media, affirming its broad utility as a stewardship tool. Crucially, the safety of SNAP is maintained through stringent patient selection criteria, transparent communication of ‘red flag’ symptoms, and robust follow-up mechanisms.

Successful implementation of SNAP critically relies on effective communication frameworks, where clinicians engage in shared decision-making, providing clear rationale and practical guidance. Equally vital are strategies that empower parents through comprehensive education, empathetic engagement, and the provision of accessible resources, fostering their active adherence to the delayed prescribing plan. When integrated within broader antimicrobial stewardship programs, SNAP acts as a powerful outpatient intervention, contributing directly to reductions in antibiotic use, slowing resistance development, and enhancing overall healthcare system efficiency.

While the adoption of SNAP has shown promise across various healthcare systems, including safety-net hospitals and diverse populations, challenges persist. These include clinician diagnostic uncertainty, time constraints, parental anxieties, and systemic barriers such as inadequate follow-up infrastructure and reimbursement models. Overcoming these hurdles will require sustained investment in education, clinical decision support, and adaptable implementation strategies tailored to specific local contexts.

Looking ahead, future research must delve deeper into the long-term epidemiological impact of SNAP on resistance patterns, comprehensive health outcomes, and cost-effectiveness. Further investigation into its applicability across diverse global settings, refining implementation science, and leveraging technological advancements will be crucial. Ethical considerations regarding equity of access and the quality of shared decision-making must also guide future endeavors.

In conclusion, SNAP is more than just a prescribing strategy; it is a holistic approach that integrates patient-centered care with public health imperatives. Its thoughtful application, supported by ongoing research and adaptive implementation, holds immense potential to strengthen antimicrobial stewardship efforts, preserve the effectiveness of antibiotics for future generations, and ensure appropriate, safe, and effective care for pediatric populations worldwide.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

References

1. Florin ME, et al. Lurie Children’s Hospital awarded $12 million by PCORI to study best approach to treat mild pneumonia in young children. EurekAlert! 2024. (eurekalert.org)

2. Laytner LA, et al. Situations predisposing primary care patients to use antibiotics without a prescription in the United States. Antimicrobial Stewardship & Healthcare Epidemiology. 2024. (cambridge.org)

3. Mallick UK, et al. Modeling the Effects of Over and Under Doses Antibiotic Treatment to Bacterial Resistance in Presence of Immune System. arXiv preprint. 2025. (arxiv.org)

4. Neuhauser M, et al. Actionable Data for Antibiotic Stewardship: Case Examples. Minnesota Department of Health. 2018. (web.health.state.mn.us)

5. Szymczak J, et al. Physicians IDs barriers to ‘no antibiotic’ strategy for pediatric viral pneumonia. Medicine.net. 2024. (medicine.net)

6. Vestin N. Study: Hospital stewardship lowers antibiotic use, infections. CIDRAP. 2024. (cidrap.umn.edu)

7. Yarrington ME, et al. Predicting Antibiotic Resistance Patterns Using Sentence-BERT: A Machine Learning Approach. arXiv preprint. 2025. (arxiv.org)

8. Zhang L, et al. Pediatric Antibiotic Stewardship for Community-Acquired Pneumonia: A Pre-Post Intervention Study. PubMed. 2024. (pubmed.ncbi.nlm.nih.gov)

9. Zhang L, et al. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. PubMed. 2024. (pubmed.ncbi.nlm.nih.gov)

10. Zhang L, et al. A National Quality Improvement Collaborative to Improve Antibiotic Use in Pediatric Infections. Pediatrics. 2024. (publications.aap.org)